Managed Healthcare Executive March 14, 2024
Denise Myshko

The new collaboration gives Prime access to Capital Rx’s claims system; Prime has become a minority investor in Capital Rx.

Prime Therapeutics will now have access to Capital Rx’s technology platform through a new alliance between the two PBMs. As part of the strategic alliance, Prime has become a minority investor in Capital Rx.

Capital Rx’s technology, JUDI, unifies pharmacy benefit management operations — from underwriting, implementation, claim adjudication, data integration, prior authorization, patient communication, client reporting, invoicing, and reimbursement.

Prime executives said the collaboration will augment Prime’s scale, financial management, clinical expertise and allow for data and systems that can be connected and integrated more efficiently. This alliance with Capital Rx enables Prime to enhance core capabilities and ensure...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Partnerships, Pharma, Pharma / Biotech, Trends
Global Inequities In Access To Drugs Costs Millions Of Lives Each Year
STAT+: New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B
Why Conflicts Of Interest May Not Be As Bad As You Think (And Besides We All Have Them!)
11 drugs now in shortage

Share This Article